ProMIS Neurosciences Inc.
PMN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374339
In the last 90 days, ProMIS Neurosciences Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in ProMIS Neurosciences Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −1 vs. Q3 2024
- Shares held
- 9.72M
- −369.8K (−3.7%) vs. Q3 2024
- Total value
- $9.21M
- −$3.40M (−27.0%) vs. Q3 2024
- New holders
- 1
- 1 more added
- Sold out
- 2
- 5 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $84.3M |
| Q1 2026 | 25 | $78.0M |
| Q4 2025 | 9 | $1.80M |
| Q3 2025 | 23 | $4.25M |
| Q2 2025 | 19 | $4.10M |
| Q1 2025 | 17 | $6.49M |
| Q4 2024 | 17 | $9.21M |
| Q3 2024 | 18 | $12.6M |
| Q2 2024 | 16 | $4.90M |
| Q1 2024 | 16 | $6.46M |
| Q4 2023 | 15 | $3.85M |
| Q3 2023 | 14 | $5.61M |
| Q2 2023 | 13 | $723.8K |
| Q1 2023 | 12 | $889.2K |
| Q4 2022 | 13 | $824.5K |
| Q3 2022 | 13 | $1.13M |
| Q2 2022 | 2 | $468.0K |
| Q1 2022 | 2 | $8.00K |
| Q4 2021 | 2 | $9.00K |
| Q3 2021 | 3 | $14.0K |
| Q2 2021 | 3 | $17.0K |
| Q1 2021 | 3 | $17.0K |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding ProMIS Neurosciences Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| National Bank of Canada | 88 | $83 | 0.00% | −333−79.1% | Reduced |
| TD Waterhouse Canada Inc. | 133 | $126 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,666 | $1.58K | 0.00% | 00.0% | Unchanged |
| Sandy Spring Bank | 3,300 | $3.13K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5,487 | $5.00K | 0.00% | +4,741+635.5% | Added |
| Claret Asset Management Corp | 11,330 | $11.0K | 0.00% | 00.0% | Unchanged |
| Scotia Capital Inc. | 12,122 | $11.5K | 0.00% | 00.0% | Unchanged |
| Fiduciary Trust Co | 13,583 | $12.9K | 0.00% | −6,425−32.1% | Reduced |
| Ieq Capital, LLC | 26,042 | $24.7K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 30,366 | $28.7K | 0.00% | 00.0% | Unchanged |
| Heights Capital Management, Inc | 160,207 | $151.7K | 0.08% | −226,687−58.6% | Reduced |
| Allostery Investments LP | 195,111 | $184.9K | 0.36% | +195,111 | New |
| Altium Capital Management LP | 581,395 | $551.0K | 0.17% | 00.0% | Unchanged |
| Ally Bridge Group (NY) LLC | 1,592,605 | $1.51M | 1.29% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 1,929,297 | $1.83M | 0.34% | 00.0% | Unchanged |
| Armistice Capital, LLC | 2,509,977 | $2.38M | 0.06% | −160,023−6.0% | Reduced |
| Great Point Partners LLC | 2,645,128 | $2.51M | 1.18% | −145,570−5.2% | Reduced |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −30,643−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −3−100.0% | Sold out |